title: An overview of QT interval assessment in safety pharmacology.
abstract: Medicinal products that prolong cardiac repolarization unintentionally, as assessed in terms of prolongation of the QT interval of the electrocardiogram, may trigger a potentially fatal arrhythmia called torsade de pointe (TDP). This lethal risk necessitates a detailed preclinical evaluation before initiating clinical trials. There are two different and complementary approaches to assess the potential of drugs to cause QT interval prolongation. The in vivo approach provides information on the potential of the compound to prolong the QT interval under near-physiological conditions. It is mostly descriptive and not explanatory in terms of mechanisms of action. The in vitro approach provides much more mechanistic information, but is far removed from the clinical situation. While both approaches appear to possess reasonable predictive value, the results may depend largely on the experimental conditions employed. This unit reviews these issues and discusses a strategy aimed at understanding the problems associated with this cardiovascular risk.
authors.affiliation: Porsolt & Partners Pharmacology, Boulogne-Billancourt, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Lacroix
authors.forename: Sandra
authors.initials: S
authors.lastname: Picard
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D004285:Dogs; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D004562:Electrocardiography / Q000187:drug effects; D006168:Guinea Pigs; D057809:HEK293 Cells; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000517:prevention & control; D018408:Patch-Clamp Techniques; D015221:Potassium Channels / Q000378:metabolism; D011817:Rabbits; D012449:Safety; D013552:Swine; D016171:Torsades de Pointes / Q000139:chemically induced* / Q000517:prevention & control
chemical_list: D015221:Potassium Channels